Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis

Prior pooled analysis of eribulin studies (301 and 305) indicated eribulin prolonged overall survival (OS) in patients with locally advanced/metastatic breast cancer (MBC) regardless of visceral or nonvisceral disease. This hypothesis-generating post hoc analysis examined the efficacy of eribulin ac...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Shaughnessy, Joyce, Cortes, Javier, Twelves, Chris, Goldstein, Lori J., Alexis, Karenza, Xie, Ran, Barrios, Carlos, Ueno, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343788/
https://www.ncbi.nlm.nih.gov/pubmed/32641747
http://dx.doi.org/10.1038/s41598-020-66980-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343788/
https://www.ncbi.nlm.nih.gov/pubmed/32641747
http://dx.doi.org/10.1038/s41598-020-66980-0

Ejemplares similares